Search by Drug Name or NDC

NDC 68180-0987-02 DROXIDOPA 100 mg/1 Details

DROXIDOPA 100 mg/1

DROXIDOPA is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is DROXIDOPA.

MedlinePlus Drug Summary

Droxidopa is used to treat symptoms (dizziness, lightheadedness, or a fainting sensation [feeling that you are about to black out]) of neurogenic orthostatic hypotension (a sudden fall in blood pressure that occurs when a person assumes a standing position caused by certain nervous system conditions). Droxidopa is in a class of medications called alpha and beta-adrenergic agonists. It works by increasing the levels of norepinephrine, a natural substance in the body.

Related Packages: 68180-0987-02
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Droxidopa

Product Information

NDC	68180-0987
Product ID	68180-987_0098094d-a0c0-4b55-9851-68aaf0109233
Associated GPIs	38700030000130
GCN Sequence Number	072023
GCN Sequence Number Description	droxidopa CAPSULE 100 MG ORAL
HIC3	J5H
HIC3 Description	ADRENERGIC VASOPRESSOR AGENTS
GCN	36088
HICL Sequence Number	040936
HICL Sequence Number Description	DROXIDOPA
Brand/Generic	Generic
Proprietary Name	DROXIDOPA
Proprietary Name Suffix	n/a
Non-Proprietary Name	DROXIDOPA
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE
Route	ORAL
Active Ingredient Strength	100
Active Ingredient Units	mg/1
Substance Name	DROXIDOPA
Labeler Name	Lupin Pharmaceuticals, Inc.
Pharmaceutical Class	Catecholamines [CS], Increased Blood Pressure [PE]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA211652
Listing Certified Through	2024-12-31

Package

NDC 68180-0987-02 (68180098702)

Pricing Information	N/A
NDC Package Code	68180-987-02
Billing NDC	68180098702
Package	500 CAPSULE in 1 BOTTLE (68180-987-02)
Marketing Start Date	2021-09-24
NDC Exclude Flag	N